This is an infection of the liver caused by tuberculosis bacteria. It often shows up as small spots or lumps in the liver. It can affect liver function.
Every report comes from a Lived member, sent anonymously.
Have you tried Isoniazid for Tuberculosis in the Liver?
Tuberculosis in the liver, also called hepatic TB, is an active tuberculosis infection that has reached the liver. Tuberculosis (TB) is a bacterial disease that most often affects the lungs, but the bacteria can travel to other organs. Liver involvement is uncommon, found in fewer than 1 in 100 people with TB, but it is serious because it is easy to mistake for other liver diseases and is usually fatal if left untreated. The most common signs are an enlarged liver, fever, weight loss, and pain or discomfort in the upper right part of the abdomen. Many people also have a cough or other breathing symptoms, because the lungs are often infected at the same time. Some develop jaundice (yellowing of the skin or eyes). None of these symptoms point specifically to TB, which is why diagnosis is often delayed. There are two main patterns. In the more common miliary form, TB spreads through the bloodstream and seeds the liver with many tiny spots, usually alongside TB in the lungs. In the local form, the infection forms one or a few larger lumps (sometimes called tuberculomas) or a pocket of pus (an abscess), often without lung disease. The local form is more likely to cause jaundice and to look like a tumor on a scan.
Hepatic TB is caused by Mycobacterium tuberculosis, the same bacterium behind lung TB. TB spreads through the air when a person with active TB in the lungs or throat coughs, sneezes, talks or sings. Most people who breathe in the bacteria never become sick; the germs stay inactive, sometimes for years. Liver TB develops when the infection becomes active and reaches the liver, most often through the bloodstream from the lungs and less often from TB in the intestines or nearby lymph nodes. The risk is highest for people whose immune system has difficulty keeping TB in check. HIV is the most important factor: it makes TB more likely to spread beyond the lungs and tends to make liver involvement more severe. Medicines that weaken the immune system (such as steroids, drugs taken after an organ transplant and some treatments for autoimmune diseases), diabetes and alcohol use disorder also raise risk. Having been born in, or spending time in, a country where TB is common increases the chance of exposure in the first place.
Because the symptoms are vague, the first step is usually suspicion: a clinician considers TB when fever, weight loss and an enlarged or painful liver occur in someone with risk factors. Blood tests often show a raised alkaline phosphatase, a liver enzyme that tends to rise when liver tissue is infiltrated or bile flow is affected, while other liver enzymes may be only mildly abnormal. A TB skin test or TB blood test can show that a person has been infected with TB at some point, but it cannot tell whether the liver is the problem. Ultrasound is often the first scan, and a CT scan of the abdomen gives a clearer picture. Neither can confirm TB. Spots or lumps in the liver can look very much like liver cancer, cancer that has spread, or an ordinary abscess, and some people have had surgery for a suspected tumor before TB was found. A chest X-ray helps look for TB in the lungs, but a normal chest X-ray does not rule out TB in the liver. Confirming the diagnosis usually requires a liver biopsy, in which a thin needle, typically guided by ultrasound, removes a small sample of liver tissue. The sample is examined under a microscope for granulomas (small clusters of immune cells that form around TB), tested with PCR, a genetic test that detects TB bacteria quickly, and grown in culture. Culture is the most definitive test, and growing the bacteria also allows testing of which antibiotics will work against them. When suspicion is high, clinicians may start treatment before every result is back.
Hepatic TB is treated with the same combination of antibiotics used for TB in the lungs. Treatment usually starts with four drugs (isoniazid, rifampin, pyrazinamide and ethambutol) for about two months, followed by isoniazid and rifampin alone. Six months is typical, and clinicians may extend treatment to 9 to 12 months when the liver disease is extensive or the bile ducts are involved. Using several drugs together is essential: it kills the bacteria and prevents them from becoming resistant. TB that is resistant to the standard drugs needs a different, often longer regimen guided by laboratory testing. The central trade-off is that several of these medicines, especially isoniazid, rifampin and pyrazinamide, can themselves injure the liver. This is the most common serious side effect of TB treatment, and it matters more when TB is already affecting the liver. Care teams check liver blood tests before and during treatment and ask about symptoms at each visit. If drug-related liver injury occurs, the regimen may be paused or changed rather than abandoned. Drinking alcohol during treatment raises the risk of liver injury. A TB liver abscess that does not shrink with medicine, or a blockage of the bile ducts, may need drainage or surgery in addition to antibiotics. For people with HIV, TB treatment is coordinated with HIV treatment, often with help from an infectious disease specialist, because the medicines interact and because starting HIV treatment can cause a temporary flare of TB inflammation.
With a complete course of treatment, most people with drug-susceptible hepatic TB recover. Fever often settles within the first couple of weeks, and appetite, weight, jaundice and liver swelling generally improve over the first two to three months. Liver blood tests can take much longer to return to normal, sometimes many months after a person feels well, so slow-moving lab results are not by themselves a sign that treatment is failing. The treatment itself is a significant commitment. It means taking several pills every day for at least six months, regular clinic visits and blood tests, and staying in close contact with the care team. Stopping early or skipping doses, even after feeling better, can let the bacteria become resistant to the medicines and make TB much harder to cure. Whether someone can pass TB to others depends on whether the lungs are also infected. TB limited to the liver does not spread through the air, but because many people with liver TB also have lung TB, the care team checks for it and advises on any precautions at home or work. Outcomes are less favorable when TB is diagnosed late, when the bacteria are drug resistant, or when HIV is advanced, and these situations call for closer follow-up.
Arrange a medical evaluation if you have fever, unexplained weight loss, night sweats, or pain and fullness in the upper right abdomen that last more than a couple of weeks, especially if you have HIV, take medicines that weaken the immune system, or have lived in or traveled to a place where TB is common. If a scan has shown a liver mass, it is reasonable to ask whether TB has been considered. During treatment, contact your care team right away for signs that the medicines may be affecting the liver: loss of appetite, nausea or vomiting without another explanation, dark urine, new or worsening yellowing of the skin or eyes, tenderness in the upper right abdomen, persistent tiredness or weakness, or a fever lasting more than three days. Also call promptly about a new rash or lasting tingling or numbness in the hands or feet. Do not simply keep taking the medicines while waiting for the next routine visit.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Tuberculosis in the Liver is like, what's helped you, or ask the community a question.